Yuko Goto-Koshino Selected Research

Chemokine CCL17

1/2021

BRAFV595E Mutation Associates CCL17 Expression and Regulatory T Cell Recruitment in Urothelial Carcinoma of Dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuko Goto-Koshino Research Topics

Disease

26	Lymphoma (Lymphomas) 12/2023 - 12/2008
25	Neoplasms (Cancer) 11/2023 - 12/2008
9	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 04/2011
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2014 - 12/2011
4	T-Cell Lymphoma (Lymphoma, T Cell) 12/2023 - 07/2017
4	Infections 01/2023 - 01/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2014 - 09/2010
3	Inflammation (Inflammations) 08/2014 - 10/2012
2	Plasmacytoma 02/2024 - 07/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 08/2014
2	Polyps 04/2020 - 04/2015
2	Histiocytic Sarcoma 07/2019 - 10/2017
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Neutropenia 02/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023
1	Mucocele 12/2023
1	Liver Cell Adenoma (Hepatocellular Adenoma) 06/2023
1	Enteritis 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Lymphocytosis 01/2022
1	Thrombophilia 08/2021
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 08/2021
1	Amyloidosis 07/2020
1	Lymphadenopathy 01/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2020
1	Cystitis 01/2020
1	Jaundice (Icterus) 03/2019
1	Anorexia 03/2019
1	Lethargy 03/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2019
1	Hyperammonemia 03/2019
1	Gallbladder Diseases (Gall Bladder Disease) 10/2018
1	Hodgkin Disease (Hodgkin's Disease) 09/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Pancreatitis 01/2017
1	Circulating Neoplastic Cells 06/2016

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2010
8	Messenger RNA (mRNA)IBA 12/2023 - 09/2010
4	Indicators and Reagents (Reagents)IBA 09/2016 - 01/2012
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2015 - 12/2008
3	Granzymes (Granzyme)IBA 12/2023 - 01/2022
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 01/2012
3	EnzymesIBA 06/2023 - 03/2019
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2017 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2013
3	Antigen Receptors (Antigen Receptor)IBA 09/2016 - 06/2015
3	ChemokinesIBA 01/2012 - 12/2011
2	MucinsIBA 12/2023 - 10/2018
2	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 06/2015
2	CytokinesIBA 05/2022 - 08/2014
2	Prednisolone (Predate)FDA LinkGeneric 04/2020 - 10/2018
2	ParaffinIBA 01/2020 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017 - 08/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 06/2015
2	C-Reactive ProteinIBA 01/2017 - 09/2011
2	NimustineIBA 06/2015 - 06/2014
2	Chemokine CX3CL1IBA 08/2012 - 01/2012
2	Chemokine ReceptorsIBA 01/2012 - 12/2011
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2012 - 09/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Blood Proteins (Serum Proteins)IBA 02/2024
1	Alkylating AgentsIBA 01/2023
1	Chlorambucil (Leukeran)FDA Link 01/2023
1	Asparaginase (Elspar)FDA Link 03/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	mogamulizumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022
1	CCR4 ReceptorsIBA 01/2021
1	Chemokine CCL17IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2020
1	Interleukin-2 Receptor alpha SubunitIBA 07/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2020
1	Leflunomide (Arava)FDA LinkGeneric 04/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	NucleotidesIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 07/2019
1	CopperIBA 03/2019
1	GlucocorticoidsIBA 10/2018
1	Protein Isoforms (Isoforms)IBA 09/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2017
1	toceranib phosphateIBA 07/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2017
1	matrigelIBA 05/2017
1	TH 302IBA 01/2017
1	ProdrugsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 08/2015

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2023 - 12/2008
6	Therapeutics 02/2024 - 04/2011
3	Immunotherapy 01/2022 - 07/2009
1	Remission Induction 11/2023
1	Aftercare (After-Treatment) 08/2021
1	Radiotherapy 04/2021
1	Molecular Targeted Therapy 05/2016